AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 271: E465-E470, 1996;
0193-1849/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Booth, B. A.
Right arrow Articles by Bar, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Booth, B. A.
Right arrow Articles by Bar, R. S.

AJP - Endocrinology and Metabolism, Vol 271, Issue 3 E465-E470, Copyright © 1996 by American Physiological Society

ARTICLES

IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments

B. A. Booth, M. Boes and R. S. Bar
Department of Internal Medicine, Veterans Administration Medical Center, Iowa City, Iowa, USA.

Insulin-like growth factor binding protein (IGFBP)-3 was exposed to plasmin, thrombin, and pregnancy serum, substances normally present at the endothelial surface in enriched concentrations. The NH2-termini of the proteolytic fragments were sequenced, and their ability to bind insulin-like growth factor (IGF) and heparin was assessed by ligand blotting. Plasmin generated at least five fragments, three beginning at the NH2-terminus of IGFBP-3 and two with NH2-termini corresponding to middle portions of IGFBP-3. The dominant fragment bound both IGF and heparin while NH2-terminal fragments bound only IGF. Thrombin generated three and serum five easily identified fragments; the dominant fragments, beginning at midportions of IGFBP-3, retained IGF and heparin affinity, whereas the remaining fragments had differential affinities for IGF and heparin. We suggest that such fragments, when generated at the endothelia surface, have the potential to alter regional vascular concentrations of IGF and thus influence both IGF and endothelial function.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B. A. Booth, M. Boes, B. L. Dake, K. L. Knudtson, and R. S. Bar
IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis
Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E52 - E58.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B. A. Booth, M. Boes, B. L. Dake, and R. S. Bar
Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3
Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E450 - E454.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. A. M. J. L. Janssen, R. P. Stolk, H. A. P. Pols, D. E. Grobbee, and S. W. J. Lamberts
Serum Total IGF-I, Free IGF-I, and IGFBP-1 Levels in an Elderly Population : Relation to Cardiovascular Risk Factors and Disease
Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 277 - 282.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online